The relationship of experimentally produced renal lesions to Bright's disease is still a major concern of present day pathology even though the problem has for many years held the attention and interest of numerous investigators. Horn, 1937 [1] 
Since Bright in 1827 [21 associated renal pathophysiology with structural alterations in the kidney, many investigators have been concerned with the study of kidney diseases, in particular their natural history. Because biopsy techniques were not available at that time, most cases of glomerulonephritis could not be studied before they had reached an end stage. In order to study the acute and early changes of glomerulonephritis and to understand their pathogenesis, experimental models were developed in laboratory animals.
Logically the experiments performed in this era were characterized by the prevailing thoughts on pathogenesis, and since glomerulonephritis was often associated with bacterial infections, investigators tried to induce such a disease in animals with bacterial toxins [3] or chemical compounds [1] . At the turn of the century it was realized that glomerulonephritis was caused by immunologic or rather allergic reactions against bacterial products [4] [5] [6] and this precipitated a series of experiments in which glomerulonephritis was induced by administration of bacteria or bacterial products [7-9], serum [10] [11] [12] [13] or purified serum proteins [14- 171. The first successful experimental model was reported by Lindemann in 1900 [18] , who succeeded to induce a proliferative glomerular lesion by injecting rats with an anti-kidney antibody. Although a proliferative lesion was recognized in the glomeruli, which appeared to be similar to that seen in human post-infectious glomerulonephritis, the human counterpart of this model was not discovered until 1967 [19] .
A major breakthrough in experimental glomerulonephritis came in 1953 when Germuth [20] introduced a form of glomerulonephritis associated with experimental serum sickness. With this model his group and that of Dixon [21] demonstrated that glomerulonephritis was caused by deposition of immune complexes which were formed in the circulation in a state of antigen excess. Another highlight in the history of experimental glomerulonephritis has been the demonstration that glomerular immune aggregates also can be formed in situ through a reaction of antibody with fixed or planted glomerular antigens [22] [23] [24] .
Moreover the elucidation of the glomerular filter as a charge © 1989 by the International Society of Nephrology and size selective barrier [25, 26] had important implications for hypotheses on the pathogenesis of immunologically-induced glomerular injury [27, 28] . And lastly progressive glomerulosclerosis spontaneously occurring in certain rat strains has contributed to our understanding of the progression of renal disease in man and its prevention [29] .
Although models of glomerulonephritis have advanced our knowledge on glomerular disease in general, the relevance of some aspects of experimental models has been questioned. The histopathological expression of several forms of glomerulonephritis shows characteristics which prove difficult to attribute to the immunological mechanisms thought to operate in experimental disease [30] , and furthermore, glomerular lesions unrelated to immunological mechanisms were shown to express a similar variety of histopathological features. For the induction of a glomerulonephritis, animals usually are immunized with large, non-physiological doses of antigen. Moreover, injection of glomerulonephritis inducing antibodies elicits an immune reaction in the host to the injected foreign proteins which complicates the disease and its pathogenesis.
Models of glomerulonephritis models induced by disturbed regulation of the immune system associated with polyclonal activation of B-lymphocytes (PBA) [31] are complicated, unlike the naturally occurring diseases, by a down-regulation [32] and therefore lack the chronic course which is characteristic for the human situation. Glomerular lesions based on autoimmune reactions of long duration can therefore be studied only in the lesions occurring spontaneously in certain mice strains 133].
Notwithstanding these objections raised by the imperfection of the glomerulonephritis models, we know that although none of the existing models presents an identical copy of a form of human glomerulonephritis, the total array of models provide a reasonable complete picture of glomerulonephritis, each model contributing essential details to this picture. Although it remains hazardous to extrapolate the results from experimental studies to human pathology, we have to acknowledge that models of glomerulonephritis have given us (and still do so) an insight in the pathogenesis of glomerulonephritis, Much less is known about the etiologic factors underlying the induction of glomerulonephritis. Promising in this respect are recent studies concerning PBA as a common cause of different forms of autoimmune glomerulonephritis, and also studies on genetically-determined vascular reactivity as a cause for progressive glomerular sclerosis.
It is not the intention of this paper to present a comprehensive overview of models of glomerulonephritis. Only some of The lesions of the autologous phase during which the animal produces antibodies against the injected protein, in principle do not differ from those in the heterologous phase, although proteinuria is a more constant feature. Eventually the disease results in chronic glomerulonephritis and renal failure [39] .
The nephritogenic antigen involved in the induction of nephrotoxic serum nephritis is a glucose containing polysaccharide isolated from the GBM by digestion with trypsin [40], but the true nature of the antigen has not been elucidated. In the human counterpart of the model, antibodies to the Goodpasture antigen are thought to react with the globular domain of type IV collagen of bovine GBM [41] . The antigens were found to have a molecular weight of 26 and 58 kD, respectively [42].
In the so-called accelerated model of nephrotoxic serum nephritis published by Naish et al [43] rats are preimmunized with IgG from the species used to prepare the anti-GEM antibody. The ensuing proliferative glomerulonephritis is associated with an influx of polymorphonuclear leucocytes and mononuclear phagocytes [44] , but also with an infiltration of T cells consisting mainly of T helper cells. This infiltrate precedes an influx of macrophages as described by Tipping, Neale and Holdsworth [45] . The same group [46] demonstrated a macrophage inhibition activity of these lymphocytes, indicating their active role in accelerated NTN. Moorthy and Abreo [47] found that in rats receiving subnephritic doses of nephrotoxic serum an increase of the proteinuria could be induced by transfer of lymphocytes sensitized to the nephrotoxic IgG.
Cyclosporine was able to prevent both T cell accumulation and the subsequent macrophage induced injury, thus suggesting a role for cell-mediated immunity experimental anti-GBM gbmerulonephritis [45] .
Autologous models of anti-GBM glomerulonephritis are known from the work of Steblay and Lepper [48] . They are induced by immunizing animals with homologous or heterologous GEM. The resulting anti-GEM antibody binds to the GEM in a linear fashion and induces a severe crescentic glomerulonephritis [49] which is sometimes associated with pulmonary hemorrhage resembling Goodpasture's syndrome in man [50] . The disease can be transferred to naive animals by antibodies present in the circulation [Sb] . EAG can be induced in a variety of species. Bolton, Tucker and Sturgill [52] were able to demonstrate an important role for cellular immunity in experimental allergic glomerulonephritis in chickens. They showed that bursectomy which abrogated antibody formation completely did not influence the occurrence of the disease, and they were able to transfer the disease to naive animals with lympho- cytes Both variants of Heymann nephritis belong to the most studied gbomerulonephritis models, and especially in the passive Heymann nephritis important discoveries were made that resulted in a better understanding of experimental nephrology in general and immune complex glomerulopathy in particular [59] . These studies have contributed enormously to the understanding of the formation and disappearance of immune aggregates in the glomerular capillary wall [60], the mechanisms leading to proteinuria [61, 62], and the role of immune regulation considering the renal tubular antigens mentioned [31] .
In this model it was demonstrated for the first time that the immune aggregates present at the epithelial side of the gbomerular filter were not deposited there from the circulation, but instead were formed in situ [22] . This local formation of glomerular immune complex aggregates was also shown to occur in other models of glomerulonephritis like passive serum sickness gbomerulopathy [63, 64], spontaneous glomerulonephritis in New Zealand white rabbits [65] , and many others.
The antigen involved in the Heymann nephritis was purified by Kerjaschki and Farquhar [66] and was shown to consist of a glycoprotein with a molecular weight of 330 kD. Apart from its presence in the tubular brush border, the antigen was shown to presence in the tubular brush border, the antigen was shown to be present on the cell membrane of the glomerular epithelial cells, especially in coated pits [671.
Soon thereafter a second breakthrough as to immune complex formation in this model was made by the group of Andres [68] . They demonstrated in vitro that following a reaction with the antibody, the antigen on the epithelial cell membrane was cross linked, clustered and subsequently shed, probably through an association with intermediate filaments like microtubules [69] . It was furthermore demonstrated in vitro that chioropromazine could prevent such a clustering and subsequent shedding [70] . The authors hypothesized that similar events may occur in vivo and that the formed aggregates are shed in the space between epithelial cells and basement membrane [68] .
Several authors are convinced that more antigens than gp330 are involved in this immune complex glomerulopathy. They claim that a glycoprotein with a molecular weight of around 100 kD might also be involved and which may be essential in plays such a role in the pathogenesis of passive Heymann nephritis. They showed that antisera from which the anti-gp9O activity had been removed did not bind to rat glomeruli after perfusion.
In addition Hogendoorn et al [771 found that antibodies directed against extracellular matrix components like laminin and collagen type IV are present in the sera used to induce passive Heymann nephritis and could also play a role in the formation of gp330 containing immune aggregates.
Sporadic reports in the literature on human nephropathology deal with the presence of tubular brush border antigens (RTE) in the glomerular aggregates of idiopathic membranous glomerulopathy. Douglas et al [78] were able to detect circulating anti-RTE antibodies in the serum of a patient with idiopathic membranous glomerulopathy. They demonstrated RTE-like antigens in the glomerular immune aggregates. These findings suggest that RTE-like antigens might play a role in the pathogenesis of some cases of human idiopathic membranous gbmerulopathy. However, since the reports on the participation of RTE antigens are limited despite an intensive search [79], and because other antigens are known to be involved in secondary membranous glomerulopathy [80], it seems likely that more membrane or planted antigens are involved in the pathogenesis of this disease.
In conclusion we can say that the study of Heymann nephritis, and especially its passive variant, has helped us understand the formation of glomerular immune aggregates. These result from binding of antibodies to glomerular epithelial antigens that subsequently are shed in the space between epithelial cell and GBM. It provided an opportunity to study the role of complement and epithelial cell detachment as causes of increased permeability of the glomerular filter. That in human glomerulonephritis identical antigens are seldomly found doesn't necessarily imply that the pathogenetic mechanism shown for this kind of glomerulonephritis is not operating in human disease. Studies along the line of those presented here for the Heymann nephritis may reveal pathogenetic antigens in man. The acute variant is induced by one bolus injection of BSA. The resulting anti-BSA antibodies combine with the antigen in the circulation to form immune complexes.
Chronic serum sickness glomerulonephritis is induced by multiple injections with BSA that are given daily in a dosage which is determined by the antibody titers in such a way that a continuous antigen excess exists and that the immune complexes which are formed therefore remain small and soluble. In both models the glomerubonephritis is thought to result from glomerular deposition of soluble immune complexes present in the circulation. Depending on their size, the immune complexes are deposited either in the glomerular capillary wall (GCW) or in the mesangium [81].
It is known that physicochemical characteristics play an important role in the deposition of immune complexes. These characteristics determine the equilibrium between immune aggregates and immune complexes on the one hand and between immune complexes and their components on the other hand, In 1982, Hoyer, Krueger and Seiler [89] demonstrated that alternating renal perfusion with heparin and the polycation protamine sulfate resulted in complexes with a localization in the GCW that roughly indicated the negatively charged sites. The in situ formation of these spherical protamine-heparin complexes was shown not to be related to the observed proteinuria [89, 90]. Following these experiments Fleuren, Grond and Hoedemaeker [91] demonstrated for the first time that in situ formation of gbomerubar immune aggregates could occur when antigens, not related to the gbomerulus, were first planted in the GCW where they were able to react subsequently with the injected antibody. With an alternating perfusion system using BSA and anti-BSA antibodies, they demonstrated the formation of immune aggregates in the GCW of isolated rat kidneys. These investigations were extended by Border and coworkers [28, 92, 93] and many other investigators [94-96] using a variety of charged antigens.
The net charge of immune complexes also influences deposition in the glomerulus. When cationized immune complexes are injected into an animal, a GCW localization may be obtained [85, 97, 98] through an interaction of the immune complexes and the intrinsic negatively charged sites of the GCW. The charge of the antigen can also influence the nature of the resulting immune complexes. Koyama et al [99] showed that both size and avidity were determined by the charge of the antigen.
Iskander and Jenette [100], Lew, Staines and Steward [83], and Lew and Steward [84] showed that high-affinity immune complexes were deposited exclusively in the mesangial area, whereas low-affinity immune complexes were localized in the GCW, suggesting that the immune complexes might easily dissociate and reform in situ in the GCW [101] [102] [103] [104] .
It can be said that the value of the serum sickness model is twofold. First it provided an insight in the formation and subsequent deposition of immune complexes in tissues. In this deposition the charge of the antigen or the net charge of the immune complexes play an important role. Moreover it showed that glomerular immune complexes also can be formed locally, especially when charged antigens are involved. These antigens first are planted in the GCW and subsequently react with circulating antibody.
Lastly, extra antigen or antibody or positively charged molecules may under certain circumstances cause disappearance of glomerular immune aggregates by competition of binding with the glomerular negative charges.
IgA glomerulopathy
Glomerulonephritis which is associated with mesangial IgA deposition includes Berger's disease, Henoch-Schönlein gbmerulonephritis and the so-called hepatic glomerulonephritis, This paper will only discuss the models associated with a mesangial deposition or local formation of IgA-containing immune complexes.
Although IgA glomerulopathy has been studied since its discovery in 1968 by Berger and Hinglais [105] , it is still not clear how the mesangial deposits can elicit tissue damage, evolve and which possible antigens may be involved. For this reason several investigators tried to induce similar glomerular lesions in animals.
The first model of IgA glomerulopathy was obtained in BABL/c mice bearing a IgA myeloma (MOPC-315) which produces antibodies with a specificity for albumin conjugated DNP [106] . IgA immune complexes were found in the glomerular mesangium in the majority of such animals in vivo and were shown to induce glomerular disease. When compared to IgG complexes formed under similar circumstances, IgA containing immune complexes were shown to have a great propensity for glomerular deposition [107] . Johnson et al [108] demonstrated that IgA containing immune complexes like those of IgG are able to elicit injury in pulmonary alveoli, by activation of complement and generation of reactive oxygen species. In models of IgA glomerulopathy it has been shown that the immune aggregates are only nephritogenic when the antigen has an independent ability of complement activation. If this is not the case, in addition to the IgA containing complexes small amounts of complement fixing IgG or 1gM antibody have to bind [109] .
Since in human IgA nephropathy infiltrating leucocytes can seldomly be found, the mechanisms of tissue injury by IgA immune complexes may be different.
Because it is believed that the mucosal immune system plays an important role in idiopathic recurrent hematuria or Berger's syndrome [105] and since deposition of IgA in the glomerular mesangium is often associated with viral respiratory or gastrointestinal syndromes, attempts have been made to obtain a model by oral immunization of animals.
Emancipator, Gallo and Lamm [1101 induced a IgA nephropathy by oral immunization of mice with ovalbumin. The features of the experimentally-induced renal lesion resembled that seen in human IgA nephropathy, in the sense that mesangial deposition of IgA was obtained. These experiments delineated the importance of the mucosal IgA immune response in the origin of this disease, especially when it is associated with a blockade of the reticulo-endothelial system [111] . Other investigators, however, reported that mice immunized orally with TNP-ovalbumin failed to induce a IgA nephropathy [112] . These studies further showed that the immune complexes contained predominantly polymeric IgA, as determined by the detection of the J-chain in the mesangial deposits [110] . The affinity of immune complexes containing polymeric IgA for the mesangium contrasts with the lack of such affinity of immune complexes containing monomeric IgA [59] . It is possible that monomeric IgA may contribute to the formation of mesangial aggregates by in situ binding. This was demonstrated by Chen, Wong and Rifai [113] who showed that binding of monomeric IgA occurred following mesangial deposition of polymeric IgA containing immune complexes.
In relation to the idea that polymeric IgA is transported to the bile circulation, investigators tried to induce mesangial IgA deposition either through ligating the bile ducts [114] or rendering livers cirrhotic [115] by carbon tetrachloride. Both regimens resulted in increased IgA containing macromolecules in the mesangium. Secretory component (SC) was also found in the mesangium in these experiments, since it is never found in mesangial deposits in clinical IgA disease, these experiments should be regarded critically as to their relevance for human disease [116] . In humans the SC-dependent biliary transport of IgA probably plays a much smaller role in the removal of polymeric IgA from the plasma than in rats [117] . 
Models of glomerulonephritis associated with polyclonal B cell activation
Common characteristics of the models described above is that they occur spontaneously or are induced by immunization with a well defined antigen. This antigen is either a normal constituent of the glomerular structures or becomes part of it by deposition from the circulation. Upon binding, humoral and/or cellular reactants cause a characteristic pattern of inflammatory injury. Under normal conditions tolerance to self-antigens of the glomerulus prevents the induction of autoimmune reactions leading to glomerulonephritis. Immunization in complete Examples of PBA associated with glomerulopathy will be presented in the next paragraphs. The first two examples deal with induced forms like allogeneic disease caused by GVH or HVG and mercuric chloride-induced glomerulopathy. Models of SLE will also be discussed as an example of spontaneously occurring PBA associated with glomerulopathy.
Al/ogeneic disease The autoimmune phenomena induced by chronic allogeneic disease can be found in murine experimental GVH disease and in HVG reactions in chimeras. GVH disease can be induced by transfer of parental lymphocytes to an Fl hybrid derived from a cross with another parent strain differing at the MHC class II region. Genetic studies have revealed that such intra-class II differences determine the susceptibility to stimulatory reactions resulting in polyclonal B cell activation and auto-immune gbmerulonephritis [121, 128, 136] . Autoantibodies develop which are directed against RBC, basement membrane antigens [1371 and a renal tubular antigen with a molecular weight of 160 kD, the pathogenicity of which is still uncertain [138] . All these specificities can also be found in normal unstimulated mice, and in increased amount upon exposure to certain stimuli, but usually they are of the 1gM subclass, whereas in GVH they are of IgG isotype [138] . The isotype switch which is under control of IL-4 is probably of major importance in conditions associated with T cell dependent PBA [139] , as was also suggested for HVG [140] and for mercury-induced autoimmune reactions [141] .
The HVG model of autoimmune disease is induced by transfer of Fl lymphocytes into neonatal mice of one of the parental strains. These mice develop tolerance to the graft but stimulate the grafted B cells semi-allogeneically because of the different MHC antigens on their T helper cells [142] . The grafted B cells are not under normal control and this noncognate T-B cell cooperation, similar as that in GVH disease results in autoantibody production and glomerulonephritis [122, 140] .
Mercuric chloride-induced glomerulopathy PBA associated With different forms of gbomerulonephritis [143] [144] [145] has been well established in rodents exposed to mercuric chloride. Depending upon the MHC and non-MHC genes [1271, rats will develop either a stimulatory syndrome characterized by PBA and glomerulonephritis, or suppression phenomena as have been described in the Lewis rat [1461. The model has been most extensively studied in the Brown-Norway rat, which develops a T cell-dependent transient syndrome of high IgE levels and IgG1 and IgG2 auto-antibodies directed against components of the glomerular basement membrane resulting in a linear and later granular distribution [1411 of immune aggregates in the GCW [123, 132, 133, 141, 143] . The early phase is associated with an increase in B and T lymphocytes, increased class II expression on lymphoid organs, epithelia of salivary glands and the tongue [141] . The recovery phase is associated with the presence of anti-idiotype antibodies [147] and suppressor T cell activity [148] that can transfer suppression to naive recipients. In vitro and in vivo studies have demonstrated that early in the disease autoreactive T cells develop. These are directed against class II antigens as well as to other undefined T cell surface antigens and are likely to play an important role in the disease [149] . In addition, mercury has been shown to induce thymic depletion [141] and to affect suppressor T cell function [150] , which may also play a permissive role in the induction of the disease.
SLE models
Murine models of lupus are often examples of PBA and glomerulonephritis which have been studied extensively, for example in murine lupus models in the (NZB x NZW)F 1 (B/W) female mice, B x SD male and MRL-lpr/lpr mice [151, 152] .
Following the report of Koffler, Schur and Kunkel [153] that in human SLE glomerulonephritis the glomerular aggregates were composed of DNA and anti-DNA, similar findings were reported for the B/W mice [154] and later in the other mouse strains [155] [156] [157] . After Izui, Lambert and Miescher [158] had demonstrated an affinity of DNA for the collagen moiety of the GBM in vitro, it was believed that apart from being deposited from the circulation, glomerular immune aggregates in SLE glomerulonephritis could also be formed in situ.
In 1984 O'Regan and Turgeon [159] found that infusion of DNA into normal mice resulted in mesangial binding and not in a binding to the GCW which did not support such in situ formation. Subsequent experiments similarly failed to demonstrate in situ formation of glomerular immune aggregates in experimental SLE [160] , and rabbits infused with preformed DNA anti-DNA immune complexes get mesangial deposits, but not localization along the glomerular capillary wall [1611. These findings questioned the importance of DNA-anti-DNA immune complexes in the pathogenesis of SLE glomerulonephritis.
Although Morimoto et al [162] reported that in SLE patients the disease activity was directly correlated with circulating immune complexes consisting of DNA-anti-DNA, Izui, Lambert and
Miescher [163] showed that only 6% of the circulating immune complexes in SLE patients consisted of DNA/anti-DNA and that at least 52% of the immune complexes were of different composition. Comparable findings have been reported for the spontaneously occurring SLE-like syndromes in mice. Cavallo, Grave, and Granholm [164] showed that the DNA anti-DNA content was low in eluates from glomeruli of B/W mice and Izui et al [165] showed that the presence of serum antibodies to single-or double-stranded DNA was not significantly associated with the occurrence of glomerulonephritis. Granholm et al [166] demonstrated that the glomerular eluates from B/W mice contained a factor that inhibited the interaction between DNA and anti-DNA. All of these studies led to the conclusion that other immune complex systems besides DNA anti-DNA could play a role in the pathogenesis of lupus nephritis.
In 1981 Izui et al [165] found a correlation between the development of fatal glomerulonephritis in B/W mice, and the presence of gp70-containing immune complexes [167] . Gp70 is a serum glycoprotein structurally related to the envelope glycoprotein of murine leukemia virus [168] . Although this virus has a virtually ubiquitous occurrence in rodents, only lupus-prone animals develop auto-antibodies against gp7O spontaneously [169] . Izui et al [165] concluded from these findings that gp7O-anti-gp7O systems fulfill a pathogenic role in experimental lupus nephritis and that genes governing the production of auto-antibodies against retroviral gp7O may be the genes mainly responsible for the segregation of spontaneous renal disease in B/W mice.
However Andrews et al [170] have recently questioned the role of the anti-gp7O immune response in murine SLE. They used a low gp7O MRL/1 cogenic mice to demonstrate that elimination of most of the serum gp7O and virtually all of the immune complexes containing gp7O had no observable effect on the course or nature of the disease.
So far it can be concluded that the spontaneously occurring SLE-like disease associated with glomerulonephritis in certain mouse strains has served as a model of human SLE glomerulonephritis. Their study has provided several competing hypotheses of pathogenetesis [171] , and further studies will be needed before it can be ascertained which of these are pertinant to clinical SLE.
Focal and segmental glomeruloscierosis
Mechanisms involved in the progression of renal disease have been studied in experimental models from the beginning of this century. But during the last decade renewed interest and the use of micropuncture and morphometry combined with phar-macological and dietary intervention have provided enormous gain in the understanding of the factors determining the progression of renal disease.
Progressive glomerulosclerosis develops in certain rat strains spontaneously with aging [172, 173] and bears a close resemblance to focal glomerulosclerosis in man, an entity first described by Habib et al [174] . Later it was recognized as a form of glomerular injury that can complicate various forms of renal disease as well as systemic disease, such as hypertension and diabetes mellitus [29] . The development of experimental progressive glomerulosclerosis can be accelerated by high protein feeding [175] , by renal ablation [1761, and by inducing systemic hypertension [177] or diabetes mellitus [178] . In addition, progressive glomerulosclerosis can develop in genetic models of hypertension with or without unilateral nephrectomy and in models of obesity [179] . Finally, progressive glomeruloselerosis has been described in models of chronic glomerular epithelial cell damage induced by puromycin aminonucleoside [180] and adriamycin [181] . It has been suggested that hemodynamic factors, and most importantly intraglomerular capillary pressures, play a crucial role in the pathogenesis of progressive glomerulosclerosis [182, 183] , via endothelial, mesangial and epithelial damage and glomerular hypertrophy [184] . Endothehal cell damage is associated with platelet aggregation and thrombosis, which may explain the beneficial effect of anticoagulatory treatment [185, 186] . The susceptibility to develop progressive glomerulosclerosis is genetically determined [29, 187] and probably depends upon the vasoactive responses to a primary glomerular injury, such as in diabetes mellitus or in minimal change disease in man, and similarly after unilateral nephrectomy or high protein feeding in experimental models [29] . Intervention aimed at lowering capillary pressure either by protein restriction (afferent constriction) or converting enzyme inhibition (efferent vasodilation) have been shown to be partially effective in preventing or retarding progressive glomerulosclerosis in experimental models [175. 181, 183, 188-190] ; it should be remembered that these treatments have other effects beside those on glomerular capillaries. Similar results have been claimed in clinical studies but more data are needed [191] [192] [193] .
The models of progressive glomeruloscierosis have provided insight in functional abnormalities that eventually lead to endstage renal failure, especially when the lesions closely resemble those of human focal glomerulosclerosis. In other models, such as experimental diabetes in rats, the lesions do not show the typical morphological picture found in man, and here extrapolation seems hazardous. In addition it should be remembered that most male rats are prone to develop progressive glomerulosclerosis with age and that man seems to be less susceptible. Genetic differences in susceptibility associated with vascular reactivity seem to be crucial in identifying individuals at risk.
Conclusion
In the eighty years during which experimental models of human glomerulonephritis have been studied, much has been learned about the mechanisms by which glomerular immune aggregates are formed, how they mediate glomerular injury, leading to an increased permeability and how progression to end-stage renal failure occurs. In recent years the emphasis of the studies has shifted towards the role of cellular immunity and mediators of inflammation. Taken together, however, the studies mentioned above have not resulted yet in a complete picture of human glomerulopathy in all its variants and its pathophysiological consequences. This is due to the fact, although believed otherwise, that it is seldom possible to obtain a disease model in which both etiology and pathogenesis are identical or even similar to human disease. The study of models often is complicated by the fact that they are induced by methods which do not occur naturally or are complicated by the induction of an immune reaction in animals which is directed against the disease-inducing antibody. Furthermore in models of glomerulonephritis resulting from autoimmunity, the induced autoimmune phenomena are downregulated so that the disease resolves spontaneously and chronic disease cannot be studied in detail.
These drawbacks however do not invalidate the observations made already. The study of a model frequently involves the elucidation of a detail, like participation of a mediator of inflammation or the mechanism causing increased permeability of the glomerulus. The results from such studies may lead to the formulation of a working hypothesis which can be used for the study of human glomerulonephritis or for development of additional models for study. Ultimately the results from such studies have proved their relevance to human nephropathology, and can lead to clinical advances such as the development of treatment modalities or even preventative measures. Until now though, this has hardly happened. The reason why results from studies of experimental glomerulonephritis are not used more often, may be due to the fact that most models were developed for the studies of pathogenetic mechanisms, which in the human situation hardly appear to be accessible for treatment. Nevertheless, the study of spontaneously-occurring autoimmune phenomena in mice and more recently of induced autoimmune phenomena by PBA have opened new and exciting possibilities for the study of etiologic factors in human glomerulopathy. Although postinfectious gbmerulonephritis has almost disappeared, additional extrinsic factors like bacteria, viruses or drugs may prove to be important in eliciting an PBA in susceptible individuals. The recognition of such a mechanism then may lead to the prevention of some forms of glomerulonephritis. 
